PubRank

Firouzeh Korangy

Author PubWeight™ 46.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008 4.23
2 Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005 2.78
3 Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008 2.56
4 Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009 2.45
5 Myeloid derived suppressor cells in human diseases. Int Immunopharmacol 2011 2.43
6 Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. J Hepatol 2013 1.80
7 Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011 1.67
8 CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. J Immunol 2010 1.57
9 Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC. J Immunother 2010 1.38
10 Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 2003 1.32
11 S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 2012 1.28
12 Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma. Immunology 2009 1.25
13 A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma. BMC Cancer 2010 1.15
14 Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 2006 1.11
15 Peptide-beta2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J Immunol Methods 2002 1.00
16 Immunotherapy of HCC. Rev Recent Clin Trials 2008 1.00
17 Hepatocellular carcinoma from an immunologic perspective. Clin Cancer Res 2013 1.00
18 Immunotherapy of hepatocellular carcinoma. J Hepatol 2006 1.00
19 Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 2012 0.95
20 Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses. Cancer Res 2006 0.93
21 Immune suppression: the hallmark of myeloid derived suppressor cells. Immunol Invest 2012 0.93
22 Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol 2007 0.92
23 Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell Oncol 2008 0.90
24 Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses. J Immunol 2012 0.87
25 IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1. Eur J Immunol 2014 0.86
26 Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma. Dig Dis 2012 0.84
27 Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells. J Immunol 2010 0.82
28 Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells. Immunology 2007 0.81
29 Radiofrequency ablation for the treatment of HCC--maybe much more than simple tumor destruction? J Hepatol 2010 0.81
30 Differential suppression of tumor-specific CD8+ T cells by regulatory T cells. J Immunol 2010 0.79
31 Peptidases released by necrotic cells control CD8+ T cell cross-priming. J Clin Invest 2013 0.79
32 Primary sterile necrotic cells fail to cross-prime CD8(+) T cells. Oncoimmunology 2012 0.78
33 Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma. Immunology 2009 0.77
34 Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner. Eur J Immunol 2015 0.77
35 Immunogenicity of necrotic cell death. Cell Mol Life Sci 2014 0.77
36 Human Th17 cells in patients with cancer: Friends or foe? Oncoimmunology 2012 0.76
37 Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC. Hepatology 2014 0.75